Abstract
Chronic inflammation caused by persistent infection is closely related to a number of cancers; these include hepatitis B (HBV) or C and hepatoma, human papilloma virus and cervical cancer, and Helicobacter pylori and gastric cancer. The first evidence of cancer prevention by vaccination in humans was provided by HBV vaccination in infants. Chronic HBV is related to approximately 60%–90% of hepatocellular carcinomas (HCC) in adults and nearly 100% of childhood HCC in areas endemic for HBV infection. The first universal HBV vaccination program was launched in Taiwan and has continued for more than 20 years. Three or four doses of HBV vaccine were given to all infants starting from the first week of life. In addition, infants of high-risk mothers (with positive hepatitis B e antigen or high HBsAg titers) were given hepatitis B immunoglobulin within 24 h after birth. At 20 years after the launch of the HBV vaccination program in Taiwan, chronic HBV infection (HBsAg seropositive) rates in the general population below 20 years of age have revealed a remarkable reduction from 10%–17% before the vaccination program to 0.7%–1.7% after the program. HCC incidence rate in children 6–14 years old also fell from 0.52–0.54 to 0.13–0.20 per 100,000 (R.R.=0.25–0.36). HCC prevention failure is mainly related to vaccine failure to prevent chronic HBV infection. The causes of vaccine failure have included intrauterine infection, vaccine escape mutants, genetic hyporesponsive-ness, and poor compliance. Future efforts to reduce vaccine failure will improve the efficacy of liver cancer prevention by HBV vaccination. The experience of HCC prevention by HBV immunization may be applied to the prevention of other infection-related cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beasley R P, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2:1129–1133
Beasley R P, Hwang LY, Lin CC, et al (1982) Incidence of hepatitis B virus infection in preschool children in Taiwan. J Infect Dis 146:198–204
Beasley R P, Hwang LY, Lin CC, et al (1983a) Incidence of hepatitis among students at a university in Taiwan. Am J Epidemiol 117:213–222
Beasley RP, Hwang LY, Lee GCY, et al (1983b) Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2:1099–1202
Camma C, Giunta M, Andreone P, Craxi A (2001) Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 34:593–602
Chang MH, Chen DS, Hsu HC, Hsu HY, Lee CY (1989) Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 64:2377–2380
Chang MH, Chen PJ, Chen J Y, et al (1991) Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepat-ology 13:316–320
Chang MH, Lee CY, Chen DS (1993) Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection. J Med Virol 40:322–325
Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336:1855–1859
Chang MH, Shau WY, Chen CJ, et al (2000) The effect of universal hepatitis B vaccination on hepatocellular carcinoma rates in boys and girls. JAMA 284:3040–3042
Chang MH, Chen T, Hsu HM, et al (2005) Problems in the prevention of childhood hepatocellular carcinoma in the era of universal hepatitis B immunization. Clin Cancer Res 11:7953–7957
Chen DS, Hsu NHM, Sung JL, et al (1987) Mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257:2597–2603
Chen HL, Chang MH, Ni YH, et al (1996) Seroepidemiology of hepatitis B virus infection in children—ten years of mass vaccination in Taiwan. JAMA 276:906–908
Chuang SE, Kuo ML, Hsu CH, et al (2000) Curcumin-containing diet inhibits diethylnitro-samine-induced murine hepatocarcinogenesis. Carcinogenesis 21:331–335
Egner PA, Wang JB, Shu YR, et al (2001) Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A 98:14601–14606
Halsey NA, Duclos P, van Damme P, et al (1999) Hepatitis B vaccine and central nervous system demyelinating diseases. Pediatr Infect Dis J 18:23–24
Hold GL, El-Omar ME (2008) Genetic aspects of inflammation and cancer. Biochem J 410:225–235
Hsu HM, Chen DS, Chuang CH, et al (1988) Efficacy of a mass hepatitis B vaccination program in Taiwan: studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA 260:2231–2235
Hsu HY, Chang MH, Chen DS, et al (1986) Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 18:301–307
Hsu HY, Chang MH, Ni YH, Chen HL (2004) Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53:1499–1503
Kersler TW, Egner PA, Wang JB, et al (2004) Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology 127[Suppl 1]:S310–S318
Larouze B, Saimot G, Lustbader ED, London WT, Werner BG, Payet M (1976) Host response to hepatitis B infection in patients with primary hepatic carcinoma and their families: a case control study in Senegal, West Africa. Lancet 2:534–538
Liaw YF, Sung JJ, Chow WC, et al (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521–1531
Moriwaki H, Shimizu M, Okuno M, Nishiwaki-Matsushima R (2007) Chemoprevention of liver carcinogenesis with retinoids: basic and clinical aspects. Hepatol Res 37[Suppl 2]:S299–302
Ni YH, Chang MH, Hsu HY, et al (1991) Hepatocellular carcinoma in childhood: clinical manifestations and prognosis. Cancer 68:1737–1741
Ni YH, Chang MH, Huang LM, et al (2001) Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after universal hepatitis B vaccination. Ann Intern Med 135:769–800
Ni YH, Huang LM, Chang MH, et al (2007) Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132:1287–1293
Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan. Int J Cancer 94:153–156
Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul P, Sarary A (1989) Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 261:3278–3281
Popper H, Gerber MA, Thung SN (1982) The relation of hepatocellular carcinoma to infection with hepatitis B and related viruses in man and animals. Hepatology 2[Suppl]:1S–9S
Ryder RW, Whittle HC, Sanneh ABK, Ajdukiewicz AB, Tulloch S, Yvonnet B (1992) Persistent hepa-titis B virus infection and hepatoma in the Gambia, West Africa. Am J Epidemiol 136:1122–1131
Shepard C W, Simard E P, Finelli L, Fiore A F, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112–125
Stevens CE, Beasley R P, Tsui J, Lee WC (1975) Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292:771–774
Tanaka H, Tukma H, Kasahara A, et al (2000) Effect of interferon therapy on the incidence of hepato-cellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients. Int J Cancer 87:741–749
Tandon BN, Tandon A (1997) Epidemiological trends of viral hepatitis in Asia. In: Rizzetto M, Purcell RH, Gerin JL, Verme G (eds) Viral hepatitis and liver disease. Edizioni Minera Medica, Turin, pp 559–561
Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH (1998) Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 133:374–377
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Chang, MH. (2009). Cancer Prevention by Vaccination Against Hepatitis B. In: Senn, HJ., Kapp, U., Otto, F. (eds) Cancer Prevention II. Recent Results in Cancer Research, vol 181. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69297-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-69297-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69296-6
Online ISBN: 978-3-540-69297-3
eBook Packages: MedicineMedicine (R0)